Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: population based cohort study.

Anders HusbyHanne Løvdal GulsethPetteri HoviJørgen Vinsløv HansenNicklas PihlströmNina GunnesTommi HärkänenJesper DahlØystein KarlstadTiina HeliöLars KøberRickard Ljung Anders Hviid

Published in: BMJ medicine (2023)

Compared with myocarditis associated with covid-19 disease and conventional myocarditis, myocarditis after vaccination with SARS-CoV-2 mRNA vaccines was associated with better clinical outcomes within 90 days of admission to hospital.

Keyphrases

sars cov
respiratory syndrome coronavirus
emergency department
coronavirus disease
healthcare
adverse drug